Search results
J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
Zacks via Yahoo Finance· 6 days agoJ&J's (JNJ) Innovative Medicines unit sales are expected to have been driven by drugs like Darzalex...
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Quartz· 3 days agoThe activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns...
Shah Capital nominates two highly qualified independent director candidates for Novavax
Morningstar· 3 days agoBelieves the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price Shah Capital which owns 6.7% of < ...
UPDATE 4-Novavax investor Shah Capital pushes for board shakeup
Reuters via Yahoo Finance· 4 days agoNovavax shareholder Shah Capital is pushing the vaccine maker to add two of its nominees to the board to help tackle "underperformance" at the company and improve its share ...
Stocks to Watch Monday: Goldman Sachs, Tesla, Apple, Salesforce
The Wall Street Journal· 3 days ago↗️ **Goldman Sachs (GS)**: The bank's earnings blew past Wall Street expectations, boosted by a jump...
J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
Zacks· 7 days agoIn the last reported quarter, the company delivered an earnings surprise of 0.88%. Sales in J&J’s Innovative Medicines segment (previously the Pharmaceutical segment) are expected to have been ...